HCC
Hirtle Callaghan & Co’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-34,800
| Closed | -$1.52M | – | 116 |
|
|
2018
Q4 | $1.52M | Hold |
34,800
| – | – | 0.13% | 30 |
|
|
2018
Q3 | $1.53M | Hold |
34,800
| – | – | 0.14% | 30 |
|
|
2018
Q2 | $1.26M | Hold |
34,800
| – | – | 0.12% | 33 |
|
|
2018
Q1 | $1.24M | Hold |
34,800
| – | – | 0.11% | 31 |
|
|
2017
Q4 | $1.26M | Sell |
34,800
-1,904
| -5% | -$68.9K | 0.12% | 31 |
|
|
2017
Q3 | $1.31M | Buy |
36,704
+34,800
| +1,828% | +$1.24M | 0.13% | 26 |
|
|
2017
Q2 | $64K | Sell |
1,904
-474
| -20% | -$15.9K | 0.01% | 51 |
|
|
2017
Q1 | $82K | Hold |
2,378
| – | – | 0.01% | 47 |
|
|
2016
Q4 | $78K | Sell |
2,378
-53,699
| -96% | -$1.76M | 0.01% | 50 |
|
|
2016
Q3 | $1.9M | Buy |
56,077
+16,642
| +42% | +$564K | 0.39% | 20 |
|
|
2016
Q2 | $1.39M | Sell |
39,435
-782
| -2% | -$27.5K | 0.26% | 23 |
|
|
2016
Q1 | $1.19M | Buy |
40,217
+33,619
| +510% | +$996K | 0.22% | 23 |
|
|
2015
Q4 | $211K | Sell |
6,598
-10,610
| -62% | -$339K | 0.05% | 52 |
|
|
2015
Q3 | $540K | Hold |
17,208
| – | – | 0.09% | 18 |
|
|
2015
Q2 | $577K | Buy |
+17,208
| New | +$577K | 0.19% | 17 |
|
|
2015
Q1 | – | Sell |
-82,114
| Closed | -$2.56M | – | 274 |
|
|
2014
Q4 | $2.56M | Buy |
82,114
+254
| +0.3% | +$7.91K | 0.59% | 33 |
|
|
2014
Q3 | $2.42M | Buy |
81,860
+17
| +0% | +$503 | 0.4% | 41 |
|
|
2014
Q2 | $2.43M | Sell |
81,843
-17
| -0% | -$505 | 0.34% | 45 |
|
|
2014
Q1 | $2.63M | Buy |
81,860
+130
| +0.2% | +$4.18K | 0.43% | 36 |
|
|
2013
Q4 | $2.5M | Buy |
81,730
+946
| +1% | +$29K | 0.34% | 40 |
|
|
2013
Q3 | $2.32M | Buy |
80,784
+68,118
| +538% | +$1.96M | 0.37% | 45 |
|
|
2013
Q2 | $355K | Buy |
+12,666
| New | +$355K | 4.11% | 8 |
|